Celsion’s Immunotherapy Candidate Impresses, Stock Surges – Zacks.com
|
Celsion’s Immunotherapy Candidate Impresses, Stock Surges
Zacks.com Celsion Corporation (CLSN – Free Report) announced results from phase Ib study — OVATION — evidently showing biological activity of its immunotherapy candidate, GEN1, in advanced ovarian cancer patients. Celsion is developing the candidate for newly … |
U.S. News & World Report |
Stem Cells May Hold the Fix | Healthcare of Tomorrow | US News
U.S. News & World Report ‘Stem cells could touch just about every area of medicine,’ experts say. new state law aims to warn consumers about potentially harmful …Modesto Bee TEDCO awards stem cell funding, $7 million more up for grabsBaltimore Business Journal TEDCO awards $1 million for stem cell projectsMaryland Daily Record |
Discover Magazine |
NCI study identifies essential genes for cancer immunotherapy
The Cancer Letter Publications A new NCI study has identified genes that are necessary in cancer cells for immunotherapy to work, addressing the problem of why some tumors don’t respond to immunotherapy or respond initially but then stop as tumor cells develop resistance to … McGill University Software Identifies Molecular Links in Tumor, Blood Transcription ProfilesGenomeWeb |
Engadget |
Spider silk and stem–cell leather are the future of fashion
Engadget An incubator called Fashion Tech Labs (FTL) is trying to break the textile pollution cycle with new tech like stem–cell leather, recycled fabrics and ultra-strong spider-silk-based fibers. At Google’s Paris Arts & Culture Center, I had a look at some … |